期刊文献+

ACEI治疗肾病综合征的临床观察 被引量:1

ACEI治疗肾病综合征的临床观察
下载PDF
导出
摘要 目的:探讨ACEI类药物对肾病综合征的治疗作用。方法:将80例患者随机均分为二组,对照组仅用泼尼松和环磷酰胺治疗,治疗组在此基础上给予依那普利。结果:8周后两组的24h尿蛋白量降低,白蛋白升高,甘油三酯和总胆固醇降低,血肌酐降低,但治疗组降低的幅度更大(P<0.05),12周后治疗组的24小时尿蛋白、胆固醇、血肌酐进一步降低(P<0.05),而对照组仅24小时尿蛋白进一步降低,其他改变无统计学差异。结论:以依那普利为代表的ACEI类药物可有效改善肾病综合征的临床症状,且用药8周即有显效,继续用药可进一步发挥作用。 Observe: To observe effect of ACEI class of drugs on the therapeutic nephrotic syndrome.Mehtod: 80 cases of therapeutic nephrotie syndrome derided into tow groups.The control group only gave prednisone and cyclophosphamide treatment while the treatment group given enalapril treatment on this basis, and compaired their urine protein, serum albumin and serum ereatinine after 8 weeks and 12 weeks treatment.Conclusion: ACEI class of drugs can effectively improve the clinical symptoms of nephrotic syndrome.There's significant effect after 8 weeks treatment and it could last long. However clinical applications need to master the ACEI class indications and contraindications.
作者 黄荣
出处 《中国民族民间医药》 2010年第2期116-117,共2页 Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词 肾病综合征 ACEI herapeutic nephrotic syndrome ACEI
  • 相关文献

二级参考文献25

  • 1唐政,宦红娣.血管紧张素Ⅱ与肾脏硬化的研究进展[J].肾脏病与透析肾移植杂志,1996,5(5):43-49. 被引量:11
  • 2Navar L G,Semin Nephrol,1997年,17卷,412页 被引量:1
  • 3Ellis D, Vats A,Moritz ML, et al.Long-term antiproteinuric and renoprotective efficacy and safety of Iosartan in children with proteinuria [ J ]. J Pediatr, 2003,143( 1 ) : 89-97. 被引量:1
  • 4White CF, Macpherson CF, Hurley RM, et al. Antiproeinuric effects of enalapril and losartan:a pilot study[J]. Pediatr Nephrol,2003,18(10) : 1038-1043. 被引量:1
  • 5Tylicki L, Renke M, Rutkowski P, et al. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis[J]. Med Sci Monit, 2005, 11(4) : PI31-37. 被引量:1
  • 6Renke M,Tylicki L, Rutkowski P, et al. Low-dose angiotensin Ⅱ receptor antagonists and angiotensin Ⅱ-convertlng enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis[J]. Seand J Urol Nephrol,2004,38(5) :427--433. 被引量:1
  • 7Praga M.Therapeutic measures in proteinuric nephropathy[J]. Kidney Int Suppl,2005, (99) :S137-141. 被引量:1
  • 8Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin Ⅱ receptor blockers to halt progression of chronic renal disease: pathophysiology and indications[J]. Kidney Int,2005,67(3) :799-812. 被引量:1
  • 9Yang Y, Ohta K, Shimizu M, et al.Treatment with low-dose angiotensinconverting enzyme inhibitor (ACE1) plus angiotensin Ⅱ receptor blocker (ARB) in pediatric patients with IgA nephropathy[J]. Clin Nephrol, 2005,64(1) :35-40. 被引量:1
  • 10Dixit MP, Dixit NM, Scott K, et al. Managing Henoeh-Schonlein purpura in children with fish oil and ACE inhibitor therapy[J]. Nephrology, (Carlton), 2004,9(6) :381-386. 被引量:1

共引文献17

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部